Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183087 · ClinicalTrials.gov registry record
Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT05183087: Completed study, sponsored by Massachusetts General Hospital.
NCT05183087 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05183087 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a pilot study to identify biomarkers that individually, and in combination, demonstrate the greatest sensitivity to repetitive, low-level blast exposure (RLLBE) neurotrauma in Special Operations Forces (SOF) personnel. The proposed cross-sectional, multimodal study will elucidate the potential effects of long-term RLLBE by comparing biomarkers across subjects.
Interventions
- DIAGNOSTIC_TEST 3T Connectome MRI
- DIAGNOSTIC_TEST 7 Tesla MRI
- DIAGNOSTIC_TEST TSPO PET
- DIAGNOSTIC_TEST Tau PET
- DIAGNOSTIC_TEST Cognitive and Behavioral Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05183087
The ClinicalTrials.gov registry entry for NCT05183087 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 3T Connectome MRI is the first listed.
NCT05183087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05183087 about?
NCT05183087 is a clinical study titled "Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members". This is a pilot study to identify biomarkers that individually, and in combination, demonstrate the greatest sensitivity to repetitive, low-level blast exposure (RLLBE) neurotrauma in Special Operations Forces (SOF) personnel. The proposed cross-sectional, multimodal study will elucidate the potenti...
What is the current status of trial NCT05183087?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-07-01. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT05183087?
The interventions under investigation include: 3T Connectome MRI (DIAGNOSTIC_TEST), 7 Tesla MRI (DIAGNOSTIC_TEST), TSPO PET (DIAGNOSTIC_TEST), Tau PET (DIAGNOSTIC_TEST), Cognitive and Behavioral Assessments (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05183087?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.